RPRX up +10.50% percent Today $RPRX High is at 10.53 and

New Post Public Reply Private Reply Replies (0) Message Board

Nov 13, 2014 at 12:35 PM

RPRX up +10.50% percent Today $RPRX High is at 10.53 and the Low 9.63 with current volume of 425,142.

Recent News posted below.

Repros Therapeutics Inc RPRX other info.
http://investorshangout.com/Repros-Therapeuti...PRX-55325/

RPRX Repros Therapeutics Inc Recent Headline News

Nasdaq stocks posting largest percentage decreases
AP - Tue Nov 11, 5:02PM CST
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
CLUB: 5.88 (-0.09), HYGS: 14.52 (-0.71), KNDI: 13.38 (-1.37), MCEP: 16.76 (+0.23), HYG.TO: 16.53 (-0.65), RPRX: 10.27 (+0.84), SHLD: 38.16 (+0.40), PAA.TO: 10.86 (+0.16), PAAS: 9.55 (+0.08), REXX: 7.27 (-0.28), AKBA: 11.42 (-0.79), GCBC: 25.32 (-2.40), ASEI: 44.52 (-0.25), MTEX: 23.05 (+0.27), PLNR: 6.90 (-0.25)

Repros Soars on Positive FDA Meeting Regarding Androxa - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 4:20PM CST
Shares of Repros Therapeutics (RPRX) shot up 56.9% following a successful meeting with the FDA regarding Androxal.
BIIB: 317.81 (-3.21), RPRX: 10.27 (+0.84), ABBV: 63.93 (+0.17), AMAG: 34.65 (-0.28)

Repros Therapeutics posts 3Q loss
Automated Insights - Mon Nov 10, 8:13AM CST
WOODLANDS, Texas (AP) _ Repros Therapeutics Inc. (RPRX) on Monday reported a loss of $7.4 million, or 32 cents per share, in its third quarter.
RPRX: 10.27 (+0.84)

Repros Therapeutics beats by $0.07
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 8:11AM CST

RPRX: 10.27 (+0.84)

Repros Therapeutics Inc.(R) Reports Third Quarter 2014 Financial Results
GlobeNewswire - Mon Nov 10, 8:00AM CST
Repros Therapeutics Inc. (Nasdaq:RPRX) today announced financial results for the third quarter ended September 30, 2014.
RPRX: 10.27 (+0.84)

Sears Soars Nearly +40% As REIT News Boosts Confidence
at The Street - Fri Nov 07, 2:42PM CST
Repros Therapeutics Inc (NASDAQ:RPRX), Sears Holdings Corp (NASDAQ:SHLD) and Allied Nevada Gold Corp. (NYSEMKT:ANV) are among the top-gaining billionaire stock picks of the day. On the losing end ar...
ANV: 1.20 (+0.07), AMSC: 1.01 (-0.07), RPRX: 10.27 (+0.84), SHLD: 38.16 (+0.40), STAY: 17.62 (-0.01)

Midday Gainers/Losers
Seeking Alpha - at Seeking Alpha - Fri Nov 07, 11:52AM CST

ROKA: 3.53 (-0.06), NES: 7.98 (-0.19), FNGN: 32.32 (+0.04), FIVN: 4.97 (+0.06), MSON: 12.17 (+0.17), SLXP: 96.04 (+0.49), SUMR: 2.87 (+0.07), RPRX: 10.27 (+0.84), QTWO: 18.00 (+0.09), EV: 41.13 (-0.27), SHLD: 38.16 (+0.40), STAY: 17.62 (-0.01), PSIX: 68.30 (-1.55), BORN: 1.49 (-0.01), URRE: 2.26 (-0.23), ECOM: 18.58 (-0.18), ICPT: 155.87 (-7.09), SAEX: 3.88 (-0.14), VPCO: 1.88 (+0.31), SZYM: 3.47 (-0.05)

Repros Therapeutics (RPRX) Stock Skyrockets After Meeting with FDA About Androxal
at The Street - Fri Nov 07, 10:07AM CST
Shares of Repros Therapeutics (RPRX) soared in morning trading Friday after the biopharmaceutical company held what it called a "constructive meeting" with the FDA regarding its testosterone-boosting drug Androxal.
RPRX: 10.27 (+0.84)

Repros jumps after FDA meeting on Androxal NDA
Seeking Alpha - at Seeking Alpha - Fri Nov 07, 9:20AM CST

RPRX: 10.27 (+0.84)

Premarket Gainers / Losers
Seeking Alpha - at Seeking Alpha - Fri Nov 07, 8:14AM CST

BEBE: 2.43 (-0.04), ANET: 77.37 (+0.13), TKMR: 16.43 (+0.33), ORBC: 6.40 (-0.17), MDRX: 12.38 (+0.43), RMTI: 11.02 (-0.22), CTIC: 2.18 (unch), SHLD: 38.16 (+0.40), UBNT: 28.51 (-0.49), RIG: 26.27 (-0.81), KGC: 2.53 (+0.07), APT: 2.87 (-0.13), ANF: 29.17 (-0.18), MITK: 3.49 (-0.17), ZNGA: 2.80 (-0.01), CNET: 2.08 (-0.07), KING: 15.43 (+1.40), NETE: 1.38 (-0.02), SLXP: 96.04 (+0.49), RPRX: 10.27 (+0.84), NADL: 4.30 (-0.64), PGNX: 6.64 (+0.03), AVNR: 13.27 (+0.09), FSLR: 47.93 (-1.66), DVA: 76.83 (+0.11), NDLS: 23.72 (-0.42), ICPT: 155.87 (-7.09), AGIO: 86.22 (-0.65), PLNR: 6.90 (-0.25)

Repros Holds Constructive Meeting With FDA Regarding Androxal(R) NDA Filing
GlobeNewswire - Thu Nov 06, 3:21PM CST
-- No New Clinical Studies Requested
RPRX: 10.27 (+0.84)

Will Repros (RPRX) Miss Estimates This Earnings Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 2:12PM CST
Repros Therapeutics Inc. (RPRX) has an earnings ESP of 0.00% and a Zacks Rank #4 (Sell).
MNK: 87.30 (-5.69), PBH: 31.65 (-0.14), RPRX: 10.27 (+0.84), HSP: 57.79 (-0.30)

63.7% Return Seen to Date on SmarTrend Repros Therapeutics Call (RPRX)
Comtex SmarTrend(R) - Mon Nov 03, 10:56AM CST
SmarTrend identified a Downtrend for Repros Therapeutics (NASDAQ:RPRX) on September 4th, 2014 at $17.86. In approximately 2 months, Repros Therapeutics has returned 63.72% as of today's recent price of $6.48.
RPRX: 10.27 (+0.84)

Technical Coverage of Pharma Stocks - Repros Therapeutics, Nektar Therapeutics, Akorn, AcelRx Pharma, and Pernix Therapeutics Holdings
PR Newswire - Mon Nov 03, 7:45AM CST
Investor-Edge has initiated coverage on the following equities: Repros Therapeutics Inc. (NASDAQ: RPRX), Nektar Therapeutics (NASDAQ: NKTR), Akorn Inc. (NASDAQ: AKRX), AcelRx Pharmaceuticals Inc. (NASDAQ: ACRX), and Pernix Therapeutics Holdings Inc. (NASDAQ: PTX). Free research on these five companies can be accessed at: http://investor-edge.com/register. On Friday, October 31, 2014, the NASDAQ Composite ended at 4,630.74, up 1.41%, the Dow Jones Industrial Average advanced 1.13%, to finish the day at 17,390.52, and the S&P 500 closed at 2,018.05, up 1.17%. The gains were broad based as all the sectors ended the session in positive. The S&P 500 Health Care Sector Index ended the day at 778.85, up 0.51%, with the index also advancing 10.60% in the previous three months. Register for your complimentary reports on these five stocks at:
ACRX: 7.04 (+0.09), PTX: 11.00 (-0.05), AKRX: 37.27 (+1.84), RPRX: 10.27 (+0.84), NKTR: 13.91 (-0.06)

Repros to Webcast Investor and Analyst Day on October 31st
GlobeNewswire - Mon Oct 27, 3:01PM CDT
Repros Therapeutics Inc.(Nasdaq:RPRX) today announced that it will host a live webcast of its Investor and Analyst Day that is being held in New York City on Friday, October 31, 2014 beginning at 7:30 a.m. Eastern Time.
RPRX: 10.27 (+0.84)

Biotech Stock Roundup: AbbVie Calls off Shire Acquisition, Will Amgen Consider Breakup? - Analyst Blog
Arpita Dutt - Zacks Investment Research - Wed Oct 22, 10:18AM CDT
Will Amgen (AMGN) go the Abbott (ABT) way and split into two separate companies?
PCYC: 138.43 (+1.06), NPSP: 29.38 (+0.21), RPRX: 10.27 (+0.84), AMGN: 160.52 (-1.41), ABBV: 63.93 (+0.17), REGN: 399.26 (-1.85), CELG: 106.95 (-1.30)

Repros Therapeutics Inc. (RPRX) Stock Research Links

RPRX Board Company Profile Buy Rating Time & Sales News Filings Financials

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Coastal’s Class Action: Credit Missteps Lead to 43% Drop

Coastal's Big Misstep: A Costly Setback Hey, when a stock drops like a rock on negative news, it's a sign for those on the sidelines to take note. Coastal Financial Corporation, known by its ticker NASDAQ: CCB, felt the hard slap of market reality when a single-day nosedive shaved off a hefty 43% of its stock value. It's all thanks to a whopper of a securities class...

dMY IV Settlement: Investor Rights and Key Dates

dMY IV Settlement: What You Need to Know Listen up, folks! If you've got a stake in dMY Technology Group, Inc. IV, there's big news brewing. We're talking class action, settlement talks, and a cool $11 million on the line. Let's crack open what this means for you as a holder of dMY IV Class A common stock during December 2021's whirlwind. Who Can Get a Piece of the...

Hexagon Composites to Release Q3 2026 Results Soon

Anticipating Hexagon's Third Quarter 2026 Results Hexagon Composites ASA, based out of Oslo, Norway, is setting the stage to release its third quarter 2026 financial results. Mark your calendars for November 6, 2026, at the early bird hour of 07:00 am CET. For those of us keen on dissecting the numbers, that's when the real action begins. Executive Insights Await A...

Vinitaly.USA 2026: Italian Wine Takes Manhattan

A Two-Day Wine Extravaganza Hits New York If Italian wine was a stock, the Vinitaly.USA 2026 gathering in New York would be a rallying cry to double down. October 26-27 is set to be a whirl of handshakes and clinking glasses at Pier 36, all under the grand vision of beefing up Italy's hold on the U.S. wine market. As the compass points to growing opportunities, one can't...

GoDaddy's Bold Stunt at the Big Apple In the noise of the New York Stock Exchange, everyone is abuzz with GoDaddy’s latest marketing push. Aptly titled 'Ink Your Link,' this campaign has NYC in its sights this weekend, targeting entrepreneurs and consumers alike. The plan is to open a unique pop-up in Manhattan where business owners can ink a temporary tattoo—a bold...

Baccarat's Luxe Campaign Courts the High-End Traveler

Shining the Spotlight on a Crystal-Clear Vision When Baccarat decides to cast its net over the high-end travel market, they're not doing it with subtlety. Nope, they're going all out, and why wouldn't they? When you've got a brand that's synonymous with luxury, you have to play the part. Enter Adriana Lima, the supermodel who could probably sell sand in the Maldives if...

WOLFX Super App Surges with 300% Growth Post-Launch

A Fast-Paced Entry into the College Scene College life isn’t getting any easier, but the WOLFX app is blazing a trail through U.S. campuses, promising to mend some of the chaos students deal with daily. It's barely taken a breath since launching just a month ago, already knitting itself into the routine of students from 104 universities in 130 cities across America -...

Think Together Marks 20 Years of ASES Impact in CA

Hands-on Learning: California's Bright Future Starts Here Who's ever thought a schoolyard's the same after three? Let me tell you, in California, it's staying alive and kicking, thanks to Think Together's whirlwind of celebrations for the After School Education and Safety (ASES) program. We're talking 450 schoolyard shindigs highlighting not just how far expanded learning...

Motor Sensor Market to Exceed $5B by 2035 Surge

Motor Sensor Market: Facing a New Era of Growth Buckle up, because this motor sensor market is gearing up for one heck of a ride. We're talking a clunky, gritty transition where the market's supposed to rev up to $5.47 billion by 2035, shooting from $3.21 billion in 2026. If you are crunching those numbers like a true market dog, that's a decent CAGR of 6.1%. But what's...

State Business Formation Trends: Key Insights for Investors

Grasping New Business Formation Shifts The fresh ink isn't dry yet on the latest figures from Registered Agents Inc, revealing a surge in entrepreneurial spark throughout the U.S. September 2026 smashed records with over 562,579 new business registrations—the first time this month crossed the half-million threshold. Quite the feat, really, showcasing a 14% uptick from...